This Brisbane biotech startup just raised a record $450 million
Brisbane-founded radiopharmaceutical company AdvanCell has raised an oversubscribed $450 million Series D round as it prepares to take its experimental prostate cancer treatment into Phase-3 clinical trials and expand manufacturing in the United States. Key Takeaways Key background AdvanCell has emerged as one of Australia’s most closely watched radiopharmaceutical companies – a form of precision […]